GlassScriptPhysician profile
Leonard Scott Sole
NPI 1679575252
$7,492.47
in general payments reported to CMS, 2019-2025
44 companies · $687 in 2025
The $687 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,157 · 2020: $1,602 · 2021: $1,234 · 2022: $1,957 · 2023: $551 · 2024: $303 · 2025: $687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,541.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $996.63 | 2019-2025 | Briviact, Nayzilam |
| Abbvie INC. | $678.08 | 2021-2025 | Ubrelvy, Botox |
| Lilly USA, LLC | $520.64 | 2019-2025 | Emgality, Reyvow, Amyvid |
| Supernus Pharmaceuticals, INC. | $481.46 | 2019-2022 | |
| Acadia Pharmaceuticals INC | $416.89 | 2019-2025 | Nuplazid |
| Allergan, INC. | $411.64 | 2019-2022 | |
| Eisai INC. | $403.95 | 2019-2024 | |
| Amgen INC. | $359.05 | 2019-2022 | |
| Avanir Pharmaceuticals, INC. | $349.24 | 2019-2022 | |
| Biogen, INC. | $294.06 | 2020-2022 | |
| Neurelis, INC. | $265.90 | 2020-2023 | Valtoco |
| Amneal Pharmaceuticals LLC | $182.42 | 2020-2024 | Crexont, Rytary |
| Emd Serono, INC. | $168.07 | 2022-2025 | Mavenclad |
| E.R. Squibb & Sons, L.L.C. | $139.46 | 2020-2021 | |
| Genentech USA, INC. | $138.13 | 2019-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonard Sole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.